Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepatitis Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepatitis Other
    Tenofovir Active in Previously Treated Chronic Hepatitis B, Including Adefovir-Resistant Virus: Presented at EASL - (DGDispatch)
    Adefovir Switch to Tenofovir at 48 Weeks Improves Viral Suppression in Patients With Chronic Hepatitis B: Presented at EASL - (DGDispatch)
    Tenofovir Disoproxil Fumarate Approved in Europe for Treatment of Chronic Hepatitis B - (DGNews)
    Entecavir Has Low Resistance Rates After 5-Year Treatment of Chronic Hepatitis B - (DGNews)
    Hepatitis E virus and chronic hepatitis in organ-transplant recipients - (N Engl J Med)

    News archive

     Recent webcasts/CME - Hepatitis Other
    • Optimizing Treatment for Chronic HBV: New Data on Management Options
    • Nucleoside Analogs Lead to Long-Term Responses in Chronic Hepatitis B
    • Issues of Drug Resistance and New Data on an Emerging Agent in Chronic HBV Infection
    • Chronic Hepatitis B Virus Infection: Review and Update
      Delivering Optimal Care: Prevention, Detection, and Management of Hepatitis B in Asian and Pacific Islander Americans

      Webcasts/CME archive

       Recent cases - Hepatitis Other
        Cholestatic Hepatitis as a Possible New Side-Effect of Oxycodone: A Case Report
        Sustained Virological and Biochemical Responses to Lamivudine and Adefovir Dipivoxil Combination in a Chronic Hepatitis B Infection Despite Mutations Conferring Resistance to Both Drugs
        Nitrofurantoin-Induced Chronic Active Hepatitis in an Elderly Woman
        Drug-Induced Hepatitis Superimposed on the Presence of Anti-SLA Antibody: A Case Report
        Acute Hepatitis Associated with Q Fever in a Man in Greece: A Case Report

        Cases archive
          




        my personal edition > hepatitis other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Caffeine Consumption Appears Protective Against Liver Injury in At-Risk Populations: Presented at DDW

        By Bruce Sylvester

        NEW ORLEANS, LA -- May 19, 2004 -- Caffeine consumption, through coffee and other beverages, correlates to lower risks of liver injury among populations at high risk for such problems, according to findings from a study reported here on May 17th at Digestive Disease Week 2004.

        James Everhart, MD, MPH, Chief, Epidemiology and Clinical Trials Branch, Division of Digestive Diseases and Nutrition, National Institute of Diabetes and Digestive and Kidney Disease (NIDDK), in Bethesda, Maryland, presented the findings.

        "In a study of nearly 6,000 adults at high risk for liver injury from excessive drinking, hepatitis B or hepatitis C, obesity or other ills, the higher the consumption of caffeinated beverages, the lower the chance of the elevated liver enzymes that signal an increased risk of liver injury," Dr. Everhart said.

        The study included 5,944 adults from the third U.S. National Health and Nutrition Examination Survey (NHANES III, 1988-1994) who were at high risk for liver injury due to excessive alcohol consumption, hepatitis B or C, iron overload, obesity, or impaired glucose metabolism.

        The investigators gathered information on patients' consumption habits for caffeine-containing coffee, tea, and soft drinks. They calculated total caffeine intake from the various sources and divided the subjects into quintiles based on caffeine consumption levels. They noted liver injury by abnormal serum alanine aminotransferase (ALT) activity of more than 43 U/L.

        Results show that elevated ALT activity appeared in 8.7% of this high-risk population (P < .05).

        In unadjusted analysis, the prevalence of liver injury declined with increased coffee consumption and with increased caffeine consumption from all sources. Following multivariate logistic regression analyses adjusting for age, sex, ethnicity, and cigarette smoking, they found that the risk of liver injury dropped with increasing coffee drinking and caffeine consumption.

        "These relationships were consistent across subgroups defined by individual risk factors for liver injury and relatively unchanged when analyses included all NHANES III participants or when limited to persons without impaired liver function and without right upper quadrant pain," the authors noted.

        The research was supported by NIDDK.


        [Presentation title: "Coffee and caffeine consumption protect against liver injury in the united states population.]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send